CNS Pharmaceuticals, Inc. Skyrocketed
Tue, Aug 22, 2023 at 07:07 PM
CNS Pharmaceuticals, Inc. (CNSP:NASDAQ) jumped higher at $1.74, a gain of 42.6%. On Tue, Aug 22, 2023, CNSP:NASDAQ touched a New 2-Week Intraday Low of $1.22. The stock appeared on our News Catalysts scanner on Mon, Aug 14, 2023 at 09:23 AM in the 'EARNINGS' category. From Tue, Aug 08, 2023, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Fri, Jun 02, 2023 at $2.98 with a volume of 9M+.
About CNS Pharmaceuticals, Inc. (CNSP:NASDAQ)
CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.
Top 10 Gainers:
- VinFast Auto Ltd. (VFS:NASDAQ), 108.87%
- Vinco Ventures Inc. (BBIG:NASDAQ), 78.57%
- CNS Pharmaceuticals, Inc. (CNSP:NASDAQ), 42.62%
- Fulcrum Therapeutics, Inc. (FULC:NASDAQ), 38.52%
- Fabrinet (FN:NYSE), 31.58%
- MicroCloud Hologram Inc. (HOLO:NASDAQ), 30.51%
- Ultralife Corporation (ULBI:NASDAQ), 30.05%
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 27.4%
- Trinity Place Holdings Inc. (TPHS:NYSEMKT), 26.51%
- Prestige Wealth Inc. (PWM:NASDAQ), 25.44%